IceCure Medical (ICCM) announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent titled “Cryoprobe”. This invention introduces a novel method for safely and efficiently extracting the cryoprobe after tissue freezing during cryoablation procedures. The cryoprobe’s tip is integrated with a heater, temperature sensor, and controlled gas pulses, enabling precise estimation and management of the cryoprobe’s external surface temperature-even while embedded in frozen tissue. Designed to be compatible with a wide range of XSense system cryoprobe types, the new cryoprobe technology is a versatile solution for multiple clinical scenarios.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCM:
- IceCure Medical Gains Israeli Approval for XSense™ Cryoablation System
- IceCure Medical receives approval in Israel for the XSense System
- IceCure Medical announces two publications for ProSense cryoablation system
- IceCure Medical files $100M mixed securities shelf
- IceCure Medical Shareholders Approve Key Agenda Items at Special Meeting